Stay updated on Nintedanib for Progressive Fibrosing ILD Clinical Trial

Sign up to get notified when there's something new on the Nintedanib for Progressive Fibrosing ILD Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nintedanib for Progressive Fibrosing ILD Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    Added a site-wide government funding notice and updated the revision tag to v3.4.1, replacing the previous v3.4.0 revision.
    Difference
    0.2%
    Check dated 2026-02-03T23:45:36.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    Show glossary added; metadata updates include 'Last Update Submitted that Met QC Criteria', 'No FEAR Act Data', and Revision: v3.4.0, while the previous labels 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and Revision: v3.3.4 were removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-27T21:28:47.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    49 days ago
    Change Detected
    Summary
    Locations section updated to include a broader list of study sites across the United States and Canada, and a revision tag v3.3.3.
    Difference
    1%
    Check dated 2025-12-23T00:32:43.000Z thumbnail image
  5. Check
    70 days ago
    Change Detected
    Summary
    Revision updated to v3.3.2. The previous revision v3.3.1 has been removed.
    Difference
    0.0%
    Check dated 2025-12-01T15:49:56.000Z thumbnail image
  6. Check
    77 days ago
    Change Detected
    Summary
    Publications section updated: added that publications are automatically filled from PubMed. The revision label was updated to v3.3.1, replacing the previous text referring to PubMed publications and revision v3.2.0.
    Difference
    0.0%
    Check dated 2025-11-24T12:39:24.000Z thumbnail image
  7. Check
    85 days ago
    Change Detected
    Summary
    Deletion of the government funding status notice at the top of the ClinicalTrials.gov page for NCT02999178. The core study content and study details remain unchanged.
    Difference
    0.2%
    Check dated 2025-11-17T06:22:04.000Z thumbnail image

Stay in the know with updates to Nintedanib for Progressive Fibrosing ILD Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nintedanib for Progressive Fibrosing ILD Clinical Trial page.